Model
Edge
Seres Therapeutics
0001826323
Filing Type
4
Filing Date
3/26/2024
Updated
3/27/24, 10:20 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership